Hans‐Georg Wirsching

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

Felix Sahm, Daniel Schrimpf, Damian Stichel et al. · The Lancet Oncology · 2017 · 854 citations · Full text

Medicine, Molecular Biology, Pathology +16

<i>MGMT</i> Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial

Michael Weller, Ghazaleh Tabatabai, Bärbel Kästner et al. · Clinical Cancer Research · 2015 · 318 citations · Full text

Medicine, Oncology, Pharmacology +17

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial

Bogdana Suchorska, Michael Weller, Ghazaleh Tabatabai et al. · Neuro-Oncology · 2016 · 251 citations · Full text

Medicine, Oncology, Surgery +17

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

Philipp Sievers, Thomas Hielscher, Daniel Schrimpf et al. · Acta Neuropathologica · 2020 · 233 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence

Leah Katz, Thomas Hielscher, Benjamin Liechty et al. · Acta Neuropathologica · 2018 · 162 citations

Life Sciences, Molecular Biology, Oncology +14